Michael Shterenshis
Research Interests
Michael Shterenshis has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Yulia Roitblat
Department of Sciences, Belkind School for Special Education, Rishon-LeZion, Israel
13 shared publications - Liliia Nehuliaieva
Department of Pediatrics, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
6 shared publications - Vitalii B. Kaliberdenko
V.I. Vernadsky Crimean Federal University Department of internal medicine no. 2 Simferopol Ukraine
4 shared publications Eden Frig-Levinson
Science Research Department, Milken Community High School, Los Angeles, USA
3 shared publications- Kadri Mametov
Emergency Department, Crimean Republican Center for Disaster Medicine and Emergency Medical Aid, Simferopol, Russia
3 shared publications - Keerthanaa Balasundaram
Department of Internal medicine No.2, V.I. Vernadsky Crimean Federal University, Simferopol, Russian Federation
3 shared publications
Latest Publications
- 1 January 2025
- Published by American Psychological Association (APA) in American Journal of Orthopsychiatry
- Vol. 95 (2) , 115-125
Immediate mental health status of refugees during the Ukrainian armed conflict of 2022.
The study assessed stressors and the immediate mental health status of the Ukrainian refugees during the ongoing Ukrainian armed conflict of 2022 and analyzed strategies for reducing anxiety levels. The questionnaire-based prospective study was undertaken in Lviv, Ukraine (five study groups) and Israel (two groups) among 27,901 refugees and 1,259 controls. We assessed the levels of anxiety with General Anxiety Disorder-7 (GAD-7; score range = 0-21, mild to severe) and Refugees' Anxiety Reasons-6 (RAR-6) with a score ranging from 30 (no anxiety) to 6 (extreme anxiety) questionnaires. RAR-6 assessed worries about personal safety, money matters, relatives under fire, the future of the country, limited medications, and general mental fatigue. The study involved refugees in the migration phase and internally displaced persons. The GAD-7 score of 16.1 +/- 2.6 (severe anxiety) showed that all participants experienced anxiety during current hostilities. The RAR-6 score of 21.8 +/- 1.7 demonstrated that participants worried about numerous acute problems, but the results varied from group to group. The refugees who moved abroad independently and without a clear goal had the worst GAD-7 score of 19.4 +/- 1.7. The refugees who traveled abroad in a group-organized manner had the best RAR-6 score of 24.8 +/- 1.5, while passing through Lviv refugees had the worst RAR-6 score of 19.0 +/- 1.6 (p = .03). During hostilities, refugees, internally displaced persons, and regular inhabitants are mentally affected to varying degrees. For refugees, group-organized travel abroad is the best option to maintain adequate mental health, followed by an internal refugee status and traveling abroad independently (the worst strategy).
- 1 January 2025
- Published by American Psychological Association (APA) in American Journal of Orthopsychiatry
- Vol. 95 (2) , 115-125
Immediate mental health status of refugees during the Ukrainian armed conflict of 2022.
The study assessed stressors and the immediate mental health status of the Ukrainian refugees during the ongoing Ukrainian armed conflict of 2022 and analyzed strategies for reducing anxiety levels. The questionnaire-based prospective study was undertaken in Lviv, Ukraine (five study groups) and Israel (two groups) among 27,901 refugees and 1,259 controls. We assessed the levels of anxiety with General Anxiety Disorder-7 (GAD-7; score range = 0-21, mild to severe) and Refugees' Anxiety Reasons-6 (RAR-6) with a score ranging from 30 (no anxiety) to 6 (extreme anxiety) questionnaires. RAR-6 assessed worries about personal safety, money matters, relatives under fire, the future of the country, limited medications, and general mental fatigue. The study involved refugees in the migration phase and internally displaced persons. The GAD-7 score of 16.1 +/- 2.6 (severe anxiety) showed that all participants experienced anxiety during current hostilities. The RAR-6 score of 21.8 +/- 1.7 demonstrated that participants worried about numerous acute problems, but the results varied from group to group. The refugees who moved abroad independently and without a clear goal had the worst GAD-7 score of 19.4 +/- 1.7. The refugees who traveled abroad in a group-organized manner had the best RAR-6 score of 24.8 +/- 1.5, while passing through Lviv refugees had the worst RAR-6 score of 19.0 +/- 1.6 (p = .03). During hostilities, refugees, internally displaced persons, and regular inhabitants are mentally affected to varying degrees. For refugees, group-organized travel abroad is the best option to maintain adequate mental health, followed by an internal refugee status and traveling abroad independently (the worst strategy).
- 25 September 2024
- Published by Taylor & Francis in Educational Gerontology
- Vol. 51 (7) , 774-784
Adolescents’ knowledge regarding Alzheimer’s disease is declining: An international study
- 25 September 2024
- Published by Taylor & Francis in Educational Gerontology
- Vol. 51 (7) , 774-784
Adolescents’ knowledge regarding Alzheimer’s disease is declining: An international study
- 17 October 2022
- Published by Elsevier in Health Policy
- Vol. 126 (12) , 1303-1309
Immediate physical needs of refugees during the Ukrainian armed conflict of 2022
- 17 October 2022
- Published by Elsevier in Health Policy
- Vol. 126 (12) , 1303-1309
Immediate physical needs of refugees during the Ukrainian armed conflict of 2022
- 1 August 2021
- Published by Bentham Science Publishers Ltd. in Central Nervous System Agents in Medicinal Chemistry
- Vol. 21 (2) , 93-103
Influence of Inosine on Cerebral Hemodynamics in Space Motion Sickness in Experimental Animals
Background: Motion sickness occurs worldwide in healthy individuals regardless of age, ethnicity, or gender. It is an acute disorder; it can also present as a chronic disorder in some individuals. Motion sickness not only includes vomiting and nausea, but also includes other features such as pallor of varying degrees, cold sweating, headache, drowsiness, increased salivation, and cranial pain, which are severe. Some of the other assessment scales can interpret sickness on exposure to virtual or visual stimulation and while travelling in different types of transport. Aim: The aim of our research is to study the effect of the drug on the level of blood flow and vascular reactivity of cerebral vessels when simulating changes in the cerebral circulation in terrestrial conditions characteristic of hypogravity. Methods: Chronic experiments were performed on non-anesthetized rabbits with large hemispheres, thalamus and hypothalamus were implanted with the needle-platinum electrodes 150 mm in diameter in the cortex, and local blood flow and vascular reactivity were recorded accordingly. Cerebrovascular disturbances were modeled using an MSAOP (motion sickness of animals in the anti-orthostatic position) with an inclined angle of 45° for 2 hours. Local blood flow (BF) was measured in ml/min/100g of tissue by the method of registration of hydrogen clearance. The vasodilator coefficient of reactivity (CrCO2) was calculated by the ratio of BF against the background of inhalation of a mixture of 7% CO2 with air to the initial BF; vasoconstrictor - in relation to BF on the background of inhalation of 100% O2 to the initial BF (CrO2). A series of experiments were carried out with different routes of drug administration: First, inosine was administered intravenously at a dose of 5 mg/kg immediately before the start of SMS modeling, same dose was administered 30 minutes before the start of exposure. As a control, we used the results of experimental animals under similar conditions without the administration of the drugs. Results: Inosine has pronounced protective properties in cerebrovascular disorders on the background of space motion sickness (SMS) modeling, which is manifested by normalization of BF and restoration of compensatory reactions of cerebral vessels. In the mechanism of cerebroprotective action of inosine, it is able to correct the metabolic processes, which play an important role and help increase the compensatory capabilities and functional stability of the cerebrovascular system under gravitational influences. Conclusion: When using inosine orally, the effects are more pronounced than when administered intravenously, which should be taken into account when using it for the prevention of cerebrovascular disorders in extreme conditions.
- 1 August 2021
- Published by Bentham Science Publishers Ltd. in Central Nervous System Agents in Medicinal Chemistry
- Vol. 21 (2) , 93-103
Influence of Inosine on Cerebral Hemodynamics in Space Motion Sickness in Experimental Animals
Background: Motion sickness occurs worldwide in healthy individuals regardless of age, ethnicity, or gender. It is an acute disorder; it can also present as a chronic disorder in some individuals. Motion sickness not only includes vomiting and nausea, but also includes other features such as pallor of varying degrees, cold sweating, headache, drowsiness, increased salivation, and cranial pain, which are severe. Some of the other assessment scales can interpret sickness on exposure to virtual or visual stimulation and while travelling in different types of transport. Aim: The aim of our research is to study the effect of the drug on the level of blood flow and vascular reactivity of cerebral vessels when simulating changes in the cerebral circulation in terrestrial conditions characteristic of hypogravity. Methods: Chronic experiments were performed on non-anesthetized rabbits with large hemispheres, thalamus and hypothalamus were implanted with the needle-platinum electrodes 150 mm in diameter in the cortex, and local blood flow and vascular reactivity were recorded accordingly. Cerebrovascular disturbances were modeled using an MSAOP (motion sickness of animals in the anti-orthostatic position) with an inclined angle of 45° for 2 hours. Local blood flow (BF) was measured in ml/min/100g of tissue by the method of registration of hydrogen clearance. The vasodilator coefficient of reactivity (CrCO2) was calculated by the ratio of BF against the background of inhalation of a mixture of 7% CO2 with air to the initial BF; vasoconstrictor - in relation to BF on the background of inhalation of 100% O2 to the initial BF (CrO2). A series of experiments were carried out with different routes of drug administration: First, inosine was administered intravenously at a dose of 5 mg/kg immediately before the start of SMS modeling, same dose was administered 30 minutes before the start of exposure. As a control, we used the results of experimental animals under similar conditions without the administration of the drugs. Results: Inosine has pronounced protective properties in cerebrovascular disorders on the background of space motion sickness (SMS) modeling, which is manifested by normalization of BF and restoration of compensatory reactions of cerebral vessels. In the mechanism of cerebroprotective action of inosine, it is able to correct the metabolic processes, which play an important role and help increase the compensatory capabilities and functional stability of the cerebrovascular system under gravitational influences. Conclusion: When using inosine orally, the effects are more pronounced than when administered intravenously, which should be taken into account when using it for the prevention of cerebrovascular disorders in extreme conditions.
- 1 June 2021
- Published by Elsevier in Surgical Oncology
- Vol. 37, 101565
The surgical management of the cavity and bone defects in enchondroma cases: A prospective randomized trial
- 1 June 2021
- Published by Elsevier in Surgical Oncology
- Vol. 37, 101565
The surgical management of the cavity and bone defects in enchondroma cases: A prospective randomized trial
- 7 May 2021
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 16 (2) , 138-145
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Introduction: Coronavirus is a group of viruses which causes diseases in mammals and birds. In humans, these family of viruses can cause the respiratory infections from mild form to fatal forms. It is preferably called as coronavirus. Formally it known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or 2019 novel coronavirus (2019- nCoV) and this disease is called as coronavirus disease 2019 (COVID-19). SARS-CoV-2 is infectious in humans and world health organization has announced that Covid-19 as a pandemic disease. Tocilizumab is a biological agent which inhibits the cytokine, interleukin 6 (IL-6 inhibitor). As SARS-CoV-2 infection leads to the development of cytokine storm syndrome, the drug tocilizumab seems to have positive effect in patients with covid-19. Purpose of the Study: To analyze and review the possible effects and efficacy of the tocilizumab (monoclonal antibody against IL-6 receptors) in SARS-CoV-2 patients. Materials and methods: The search strategy on recent research and review articles is used for the SARS-CoV-2 disease and their characteristics. Furthermore we have analyzed most recent research article on monoclonal antibody against IL-6 receptors (tocilizumab) and their possible clinical effects in Covid-19 and their clinical trials on Covid-19 patients. Results and Conclusion: Covid-19 is a disease caused by SARS-CoV-2 infection. It is a life threatening condition which can give rise to fatal outcomes if left untreated. However there are no approved treatment for covid-19 globally. Furthermore we can conclude that SARS-CoV-2 is associated with worsening of lung conditions characterized by interstitial pneumonia with acute respiratory distress syndrome as a result of cytokine storm syndrome. According to available research data tocilizumab, a recombinant humanized anti-human monoclonal antibody of IgG1τ (gamma 1, kappa) can improve patient’s condition from cytokine storm syndrome by inhibiting the IL-6 (Interleukin 6) receptors. The rational use of the tocilizumab in severe and critically ill covid-19 patients can prevent the development of irreversible lung injury and death of the patient. Three retrospective studies of Xiaoling Xu et al., Pan luo et al. and Paola Tonaiti et al. has shown the efficacy of tocilizumab in severe and critically ill covid-19 patients. However we need more randomized research studies with significant number of patients which can confirm the promising results on tocilizumab treatment in covid-19 patients and even ongoing clinical trails such as TOSCA, COVACTA results has not been published yet which are expected to give better and more significant results on tocilizumab’s effectiveness and safety.
- 7 May 2021
- Published by Bentham Science Publishers Ltd. in Reviews on Recent Clinical Trials
- Vol. 16 (2) , 138-145
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Introduction: Coronavirus is a group of viruses which causes diseases in mammals and birds. In humans, these family of viruses can cause the respiratory infections from mild form to fatal forms. It is preferably called as coronavirus. Formally it known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or 2019 novel coronavirus (2019- nCoV) and this disease is called as coronavirus disease 2019 (COVID-19). SARS-CoV-2 is infectious in humans and world health organization has announced that Covid-19 as a pandemic disease. Tocilizumab is a biological agent which inhibits the cytokine, interleukin 6 (IL-6 inhibitor). As SARS-CoV-2 infection leads to the development of cytokine storm syndrome, the drug tocilizumab seems to have positive effect in patients with covid-19. Purpose of the Study: To analyze and review the possible effects and efficacy of the tocilizumab (monoclonal antibody against IL-6 receptors) in SARS-CoV-2 patients. Materials and methods: The search strategy on recent research and review articles is used for the SARS-CoV-2 disease and their characteristics. Furthermore we have analyzed most recent research article on monoclonal antibody against IL-6 receptors (tocilizumab) and their possible clinical effects in Covid-19 and their clinical trials on Covid-19 patients. Results and Conclusion: Covid-19 is a disease caused by SARS-CoV-2 infection. It is a life threatening condition which can give rise to fatal outcomes if left untreated. However there are no approved treatment for covid-19 globally. Furthermore we can conclude that SARS-CoV-2 is associated with worsening of lung conditions characterized by interstitial pneumonia with acute respiratory distress syndrome as a result of cytokine storm syndrome. According to available research data tocilizumab, a recombinant humanized anti-human monoclonal antibody of IgG1τ (gamma 1, kappa) can improve patient’s condition from cytokine storm syndrome by inhibiting the IL-6 (Interleukin 6) receptors. The rational use of the tocilizumab in severe and critically ill covid-19 patients can prevent the development of irreversible lung injury and death of the patient. Three retrospective studies of Xiaoling Xu et al., Pan luo et al. and Paola Tonaiti et al. has shown the efficacy of tocilizumab in severe and critically ill covid-19 patients. However we need more randomized research studies with significant number of patients which can confirm the promising results on tocilizumab treatment in covid-19 patients and even ongoing clinical trails such as TOSCA, COVACTA results has not been published yet which are expected to give better and more significant results on tocilizumab’s effectiveness and safety.
- 6 January 2021
- Published by Wiley in Journal of School Health
- Vol. 91 (2) , 146-154
Thermal Comfort in School Classes in the Era of Global Warming: A Prospective Multicenter Study
BACKGROUND: We investigated adolescents' feelings of thermal comfort during the educational process in various geographical locations far apart and present recommendations for the adjustment of the thermal environment in schools.METHODS: The prospective international multicenter study took place in 8 locations on different continents. The survey in the form of a questionnaire was carried out among 2800 healthy high school students. The study was divided into “cold season survey,” “warm‐season survey,” and heat wave survey.RESULTS: The statistically significant difference between the “cold season survey” score of 4.04 (discomfort) and “warm‐season survey” score of 3.47 (slight discomfort) (p = .04) indicates that students feel more thermal discomfort during winter months in all 8 locations. The heat wave survey score was 4.53 (discomfort). During the cold season, 29.24% of high school students felt themselves in full thermal comfort and 76.48% of the students felt themselves relatively comfortable (slightly cool—comfortable—slightly warm).CONCLUSIONS: Even during the ongoing process of climate change, the cold season discomfort remains the main problem for students in classes. This tendency is present in different continents as a universal problem. We recommend keeping an entrance hall and classroom temperatures at different levels and to advise students about proper clothing.
- 6 January 2021
- Published by Wiley in Journal of School Health
- Vol. 91 (2) , 146-154
Thermal Comfort in School Classes in the Era of Global Warming: A Prospective Multicenter Study
BACKGROUND: We investigated adolescents' feelings of thermal comfort during the educational process in various geographical locations far apart and present recommendations for the adjustment of the thermal environment in schools.METHODS: The prospective international multicenter study took place in 8 locations on different continents. The survey in the form of a questionnaire was carried out among 2800 healthy high school students. The study was divided into “cold season survey,” “warm‐season survey,” and heat wave survey.RESULTS: The statistically significant difference between the “cold season survey” score of 4.04 (discomfort) and “warm‐season survey” score of 3.47 (slight discomfort) (p = .04) indicates that students feel more thermal discomfort during winter months in all 8 locations. The heat wave survey score was 4.53 (discomfort). During the cold season, 29.24% of high school students felt themselves in full thermal comfort and 76.48% of the students felt themselves relatively comfortable (slightly cool—comfortable—slightly warm).CONCLUSIONS: Even during the ongoing process of climate change, the cold season discomfort remains the main problem for students in classes. This tendency is present in different continents as a universal problem. We recommend keeping an entrance hall and classroom temperatures at different levels and to advise students about proper clothing.
- 1 January 2021
- Published by Elsevier in Sleep Medicine
- Vol. 77, 177-183
Owls and larks do not exist: COVID-19 quarantine sleep habits
- 1 January 2021
- Published by Elsevier in Sleep Medicine
- Vol. 77, 177-183
Owls and larks do not exist: COVID-19 quarantine sleep habits
- 2 December 2020
- Published by Mathematical Modelling and Numerical Simulation with Applications in Journal of Pediatric Neurology
- Vol. 19 (05) , 303-311
Reassessment of Pediatric Tension-Type Headaches
A retrospective multicenter chart review was conducted with the objective of evaluating the hypothesis that certain cases diagnosed as tension-type headache (TTH) in pediatric neurology are not stress-related or central sensitization-related conditions but may mimic an autoimmune disorder of the dura mater. Of the 29,642 patient charts reviewed, 12,424 charts (42%) were excluded because of incomplete data and 17,218 cases were analyzed. For all the 29,642 charts, TTH or chronic daily headaches were diagnosed in 29.2% of cases. Among the 17,218 cases subjected to detailed diagnostic procedures, TTH was diagnosed in only 5%. In 7,044 cases, the initial diagnosis of TTH was changed to headache attributed to infection (87.4%), which was supported by the presence of meningeal signs, high antistreptolysin-O titers, and, in 46% of cases, magnetic resonance imaging (MRI)-detected thickening of the cranial dura mater. The initial diagnosis of migraine was confirmed in 87.7% of cases (8,034/9,162). In some cases of treatment-resistant pediatric recurrent headaches, which are initially diagnosed as TTH, a secondary type of headache may be suspected as the underlying cause. Usually this type of headache has streptococcal infection-related laboratory findings, the meninges as the site of the lesion, and meningism as the clinical presentation.
- 2 December 2020
- Published by Mathematical Modelling and Numerical Simulation with Applications in Journal of Pediatric Neurology
- Vol. 19 (05) , 303-311
Reassessment of Pediatric Tension-Type Headaches
A retrospective multicenter chart review was conducted with the objective of evaluating the hypothesis that certain cases diagnosed as tension-type headache (TTH) in pediatric neurology are not stress-related or central sensitization-related conditions but may mimic an autoimmune disorder of the dura mater. Of the 29,642 patient charts reviewed, 12,424 charts (42%) were excluded because of incomplete data and 17,218 cases were analyzed. For all the 29,642 charts, TTH or chronic daily headaches were diagnosed in 29.2% of cases. Among the 17,218 cases subjected to detailed diagnostic procedures, TTH was diagnosed in only 5%. In 7,044 cases, the initial diagnosis of TTH was changed to headache attributed to infection (87.4%), which was supported by the presence of meningeal signs, high antistreptolysin-O titers, and, in 46% of cases, magnetic resonance imaging (MRI)-detected thickening of the cranial dura mater. The initial diagnosis of migraine was confirmed in 87.7% of cases (8,034/9,162). In some cases of treatment-resistant pediatric recurrent headaches, which are initially diagnosed as TTH, a secondary type of headache may be suspected as the underlying cause. Usually this type of headache has streptococcal infection-related laboratory findings, the meninges as the site of the lesion, and meningism as the clinical presentation.
- 1 December 2020
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 139, 110282
Stay-at-home circumstances do not produce sleep disorders: An international survey during the COVID-19 pandemic
- 1 December 2020
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 139, 110282
Stay-at-home circumstances do not produce sleep disorders: An international survey during the COVID-19 pandemic